Back to today’s briefing

Story perspectives

FDA Accepts Aquestive's Anaphylm™: Allergy Treatment Breakthrough Ahead

6/17/2025

46 7

Summary

Story summary

Aquestive Therapeutics is on the brink of a breakthrough with the FDA's acceptance of its New Drug Application for Anaphylm™, an innovative oral epinephrine film aimed at combating severe allergic reactions. Set to receive a decision by January 31, 2026, this could revolutionize treatment, offering a convenient, everyday solution without the need for special storage.

1 of 1

Story summary

Aquestive Therapeutics is on the brink of a breakthrough with the FDA's acceptance of its New Drug Application for Anaphylm™, an innovative oral epinephrine film aimed at combating severe allergic reactions. Set to receive a decision by January 31, 2026, this could revolutionize treatment, offering a convenient, everyday solution without the need for special storage.